415 related articles for article (PubMed ID: 16944406)
1. The concepts of remission and recovery in schizophrenia.
Leucht S; Lasser R
Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
[TBL] [Abstract][Full Text] [Related]
2. Improving patient outcomes in schizophrenia: achieving remission.
Nasrallah HA; Lasser R
J Psychopharmacol; 2006 Nov; 20(6 Suppl):57-61. PubMed ID: 17046987
[TBL] [Abstract][Full Text] [Related]
3. The concepts of remission and recovery in schizophrenia.
Emsley R; Chiliza B; Asmal L; Lehloenya K
Curr Opin Psychiatry; 2011 Mar; 24(2):114-21. PubMed ID: 21285703
[TBL] [Abstract][Full Text] [Related]
4. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
Motlová L; Spaniel F; Höschl C; Balon R
Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
6. Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
Burton S
J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984
[TBL] [Abstract][Full Text] [Related]
7. Defining and achieving recovery from bipolar disorder.
Harvey PD
J Clin Psychiatry; 2006; 67 Suppl 9():14-8; discussion 36-42. PubMed ID: 16965184
[TBL] [Abstract][Full Text] [Related]
8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
9. [Self-efficacy and remission in schizophrenia].
Tartas M
Psychiatr Pol; 2002; 36(6 Suppl):249-55. PubMed ID: 12647446
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
11. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
12. Definitions of the term 'recovered' in schizophrenia and other disorders.
Faerden A; Nesvåg R; Marder SR
Psychopathology; 2008; 41(5):271-8. PubMed ID: 18594161
[TBL] [Abstract][Full Text] [Related]
13. A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis.
Menezes NM; Malla AM; Norman RM; Archie S; Roy P; Zipursky RB
Acta Psychiatr Scand; 2009 Aug; 120(2):138-46. PubMed ID: 19207130
[TBL] [Abstract][Full Text] [Related]
14. Recovery from schizophrenia and the recovery model.
Warner R
Curr Opin Psychiatry; 2009 Jul; 22(4):374-80. PubMed ID: 19417668
[TBL] [Abstract][Full Text] [Related]
15. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
Chue P
J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
[TBL] [Abstract][Full Text] [Related]
16. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
17. [Recovery and remission in schizophrenia. Results from a naturalistic 2-year follow-up inpatient study].
Wolter A; Preuss U; Krischke N; Wong JW; Langosch JM; Zimmermann J
Fortschr Neurol Psychiatr; 2010 Aug; 78(8):468-74. PubMed ID: 20694939
[TBL] [Abstract][Full Text] [Related]
18. Remission in schizophrenia: analysis in a naturalistic setting.
Eberhard J; Levander S; Lindström E
Compr Psychiatry; 2009; 50(3):200-8. PubMed ID: 19374962
[TBL] [Abstract][Full Text] [Related]
19. [Neurobiology and treatment of mentalisation in schizophrenia].
Herold R; Tényi T
Neuropsychopharmacol Hung; 2005 Dec; 7(4):187-93. PubMed ID: 16496483
[TBL] [Abstract][Full Text] [Related]
20. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
